Tender

Community Pharmacy COVID-19 Vaccination Programme Phase 5 2021/22

NHS ENGLAND

This public procurement record has 6 releases in its history.

TenderUpdate

11 Jul 2022 at 07:36

Tender

29 Jun 2022 at 15:48

Tender

20 May 2022 at 13:17

TenderUpdate

25 Nov 2021 at 16:11

Tender

25 Nov 2021 at 16:11

Tender

15 Jul 2021 at 16:25

Summary of the contracting process

The National Health Service Commissioning Board, known as NHS England, is initiating the Community Pharmacy COVID-19 Vaccination Programme Phase 5 for 2021/22. This procurement process, classified under health services, seeks to establish local enhanced services arrangements with community pharmacies in the UK where there is identified additional COVID-19 vaccination capacity. The tender period is currently active, with bids required to be submitted by 19 July 2022 at 17:00. Successful community pharmacies will administer vaccinations at designated locations according to the terms of the local enhanced services agreements.

This opportunity presents a significant chance for community pharmacies to expand their services and increase operational capacity in the healthcare sector. Businesses that are well-suited to compete include those with established pharmacy services capable of handling vaccination logistics, as well as those focused on community health. By participating in this programme, pharmacies can not only contribute to public health efforts but also enhance their visibility and service offerings, potentially leading to long-term partnerships with NHS England.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Community Pharmacy COVID-19 Vaccination Programme Phase 5 2021/22

Notice Description

The National Health Service Commissioning Board (which uses the operational name "NHS England") is seeking to enter into local enhanced services arrangements with community pharmacies in geographical areas where NHS England identifies there is a need for additional COVID-19 vaccination capacity. Successful community pharmacies will provide COVID-19 vaccination services under a local enhanced services agreement at designated sites operated by the pharmacies.https://www.england.nhs.uk/coronavirus/covid-19-vaccination-programme/primary-care-guidance/https://cv19pharmacyeoi.necsu.nhs.uk/

Lot Information

Lot 1

NHS is a global leader in achieving high levels of vaccination coverage, and this has been reflected in a hugely successful COVID-19 vaccination programme. Community pharmacy has played a critical role in the success of phase 1 (the vaccination of patient JCVI cohorts 1-9) and phase 2 (the vaccination of patient JCVI cohorts 10-12) of the COVID-19 vaccination programme. Through their strong relationships in local places and neighbourhoods, community pharmacies have helped to tackle vaccine inequalities and improve vaccination take-up.
The fifth phase of the COVID-19 vaccination programme will offer booster (with additional vaccine) for those at the highest risk, to maintain protection against the risk of severe illness, and continue to offer initial vaccinations to those Patients who did not take up or were previously not eligible to receive vaccination in phases 1 and 2.
The service will be provided as a Local Enhanced Service (LES) pursuant to the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013. The Community Pharmacy Phase 5 Site Designation Process document sets out the detail of how Pharmacy Contractor can submit expressions of interest for providing the LES and how Pharmacy Contractors who are able to provide the LES will be identified at a regional basis on the basis of site. The LES Agreement document sets out the requirements of service provision. A LES Agreement will be entered into between NHS England and a Pharmacy Contractor selected by NHS England via the Site Designation Process which is set out in the Community Pharmacy Phase 5 Site Designation Process document but only where there is a local population need for additional COVID-19 vaccination services and where NHS England considers the relevant Pharmacy Contractor is best placed to meet that need having applies the criteria, process and steps outlined in the Community Pharmacy Phase 5 Site Designation Process document.
For the avoidance of doubt, this is a voluntary Contract Notice in the interests of achieving maximum transparency and sectoral awareness. NHS England is empowered to facilitate LES Agreements on a site by site basis pursuant to the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013.
The items of service payment of PS10.06 per vaccination administered to a Patient

Options: There is an ability to extend the LES Agreement for 6 months by agreement between the parties for up to 6 months.

Renewal: NHS England may allow Pharmacy Contractors a new opportunity to submit expressions of interest depending on the requirements of the COVID-19 Vaccination Program.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-02c88c
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/018842-2022
Current Stage
Tender
All Stages
Tender

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services


CPV Codes

85100000 - Health services

85323000 - Community health services

Notice Value(s)

Tender Value
£10 Under £100K
Lots Value
£10 Under £100K
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
11 Jul 20223 years ago
Submission Deadline
19 Jul 2022Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Active
Lots Status
Active
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
NHS ENGLAND
Additional Buyers

THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)

Contact Name
Natalie Hailwood
Contact Email
natalie.hailwood@nhs.net
Contact Phone
Not specified

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Post Town
Warrington
Country
England

Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified

Local Authority
Leeds
Electoral Ward
Little London & Woodhouse
Westminster Constituency
Leeds Central and Headingley

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-02c88c-2022-07-11T08:36:56+01:00",
    "date": "2022-07-11T08:36:56+01:00",
    "ocid": "ocds-h6vhtk-02c88c",
    "description": "This is a voluntary Contract Notice. LES Agreements are authorised pursuant to direction 14 of the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013. In any event, the services in scope are healthcare services which fall under \"social and other specific services\" in Section 7.. All Pharmacy Contractors that submit Expressions of Interest will set out in Stage 1 of Designation Process (as set out in the Community Pharmacy Phase 3 Designation Process document) will then go through a prioritisation process with the application of locality specific criteria to identify Priority Sites which will then go through an assurance process. Any such Assured Sites will then be subject to an assessment of readiness preparation with NHS England. Where NHS England is so satisfied, the site will be approved and a LES Agreement offered. If NHS England considers that there is a need for additional COVID-19 vaccination services in a geographical area covered by the Pharmacy Contractor who submitted an Expression of Interest, NHS England may either publish an invitation to submit new Expressions of Interest with specific detail as to the specific requirements or revisit the Expressions of Interest originally submitted and progress other Pharmacy Contractors through the Designation Process again. There will be no maximum number of Pharmacy Contractors that may be offered a LES Agreement. Each LES Agreement is likely to be below the financial threshold for services.",
    "initiationType": "tender",
    "tender": {
        "id": "ocds-h6vhtk-02c88c",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Community Pharmacy COVID-19 Vaccination Programme Phase 5 2021/22",
        "status": "active",
        "classification": {
            "scheme": "CPV",
            "id": "85100000",
            "description": "Health services"
        },
        "mainProcurementCategory": "services",
        "description": "The National Health Service Commissioning Board (which uses the operational name \"NHS England\") is seeking to enter into local enhanced services arrangements with community pharmacies in geographical areas where NHS England identifies there is a need for additional COVID-19 vaccination capacity. Successful community pharmacies will provide COVID-19 vaccination services under a local enhanced services agreement at designated sites operated by the pharmacies.https://www.england.nhs.uk/coronavirus/covid-19-vaccination-programme/primary-care-guidance/https://cv19pharmacyeoi.necsu.nhs.uk/",
        "lots": [
            {
                "id": "1",
                "description": "NHS is a global leader in achieving high levels of vaccination coverage, and this has been reflected in a hugely successful COVID-19 vaccination programme. Community pharmacy has played a critical role in the success of phase 1 (the vaccination of patient JCVI cohorts 1-9) and phase 2 (the vaccination of patient JCVI cohorts 10-12) of the COVID-19 vaccination programme. Through their strong relationships in local places and neighbourhoods, community pharmacies have helped to tackle vaccine inequalities and improve vaccination take-up.<br/>The fifth phase of the COVID-19 vaccination programme will offer booster (with additional vaccine) for those at the highest risk, to maintain protection against the risk of severe illness, and continue to offer initial vaccinations to those Patients who did not take up or were previously not eligible to receive vaccination in phases 1 and 2.<br/>The service will be provided as a Local Enhanced Service (LES) pursuant to the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013. The Community Pharmacy Phase 5 Site Designation Process document sets out the detail of how Pharmacy Contractor can submit expressions of interest for providing the LES and how Pharmacy Contractors who are able to provide the LES will be identified at a regional basis on the basis of site. The LES Agreement document sets out the requirements of service provision. A LES Agreement will be entered into between NHS England and a Pharmacy Contractor selected by NHS England via the Site Designation Process which is set out in the Community Pharmacy Phase 5 Site Designation Process document but only where there is a local population need for additional COVID-19 vaccination services and where NHS England considers the relevant Pharmacy Contractor is best placed to meet that need having applies the criteria, process and steps outlined in the Community Pharmacy Phase 5 Site Designation Process document.<br/>For the avoidance of doubt, this is a voluntary Contract Notice in the interests of achieving maximum transparency and sectoral awareness. NHS England is empowered to facilitate LES Agreements on a site by site basis pursuant to the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013.<br/>The items of service payment of PS10.06 per vaccination administered to a Patient",
                "contractPeriod": {
                    "durationInDays": 90
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "NHS England may allow Pharmacy Contractors a new opportunity to submit expressions of interest depending on the requirements of the COVID-19 Vaccination Program."
                },
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "hasOptions": false,
                "options": {
                    "description": "There is an ability to extend the LES Agreement for 6 months by agreement between the parties for up to 6 months."
                },
                "status": "active",
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "price"
                        }
                    ]
                },
                "value": {
                    "amount": 10.06,
                    "currency": "GBP"
                }
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    },
                    {
                        "region": "UK"
                    },
                    {
                        "region": "UK"
                    },
                    {
                        "region": "UK"
                    }
                ],
                "relatedLot": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "85323000",
                        "description": "Community health services"
                    }
                ]
            }
        ],
        "submissionMethod": [
            "electronicSubmission",
            "written"
        ],
        "submissionMethodDetails": "https://health-family.force.com/s/Welcome",
        "communication": {
            "atypicalToolUrl": "https://health-family.force.com/s/Welcome"
        },
        "selectionCriteria": {
            "criteria": [
                {
                    "type": "suitability",
                    "description": "Pursuant to direction 14 of the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013, NHS England is only authorised to arrange for the provision of an enhanced service with Pharmacy Contractors which are defined as persons included in a list prepared under regulation 10(2)(a) of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013",
                    "appliesTo": [
                        "supplier"
                    ]
                }
            ]
        },
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "tenderPeriod": {
            "endDate": "2022-07-19T17:00:00+01:00"
        },
        "submissionTerms": {
            "languages": [
                "en"
            ],
            "bidValidityPeriod": {
                "durationInDays": 90
            }
        },
        "awardPeriod": {
            "startDate": "2022-06-29T12:00:00+01:00"
        },
        "bidOpening": {
            "date": "2022-06-29T12:00:00+01:00"
        },
        "hasRecurrence": true,
        "amendments": [
            {
                "id": "1",
                "unstructuredChanges": [
                    {
                        "oldValue": {
                            "date": "2021-11-30T17:00:00Z"
                        },
                        "newValue": {
                            "date": "2021-12-02T17:00:00Z"
                        },
                        "where": {
                            "section": "IV.2.2.1",
                            "label": "Deadline for EOI date"
                        }
                    }
                ]
            },
            {
                "id": "2",
                "unstructuredChanges": [
                    {
                        "newValue": {
                            "date": "2023-03-31"
                        },
                        "where": {
                            "section": "II.2.7.4",
                            "label": "End Date"
                        }
                    }
                ]
            }
        ],
        "value": {
            "amount": 10.06,
            "currency": "GBP"
        }
    },
    "parties": [
        {
            "id": "GB-FTS-2505",
            "name": "The NHS Commissioning Board (operating under the name of NHS England)",
            "identifier": {
                "legalName": "The NHS Commissioning Board (operating under the name of NHS England)"
            },
            "address": {
                "streetAddress": "2nd Floor, Rutland House",
                "locality": "Runcorn",
                "region": "UK",
                "postalCode": "WA7 2ES",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Natalie Hailwood",
                "email": "natalie.hailwood@nhs.net",
                "url": "http://health.atamis.co.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.england.nhs.uk/",
                "buyerProfile": "https://www.england.nhs.uk/",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "MINISTRY",
                        "description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-497",
            "name": "The High Court",
            "identifier": {
                "legalName": "The High Court"
            },
            "address": {
                "streetAddress": "Strand",
                "locality": "London",
                "postalCode": "WC2A 2LL",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "generaloffice@administrativecourtoffice.justice.gov.uk"
            },
            "roles": [
                "reviewBody"
            ],
            "details": {
                "url": "https://www.gov.uk/courts-tribunals"
            }
        },
        {
            "id": "GB-FTS-3717",
            "name": "NHS England",
            "identifier": {
                "legalName": "NHS England"
            },
            "address": {
                "streetAddress": "Quarry House",
                "locality": "Leeds",
                "region": "UKE",
                "postalCode": "LS2 7UE",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Natalie Hailwood",
                "email": "natalie.hailwood@nhs.net",
                "url": "https://health-family.force.com/s/Welcome"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.england.nhs.uk//",
                "buyerProfile": "https://www.england.nhs.uk//",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "MINISTRY",
                        "description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-3717",
        "name": "NHS England"
    },
    "language": "en"
}